SBC Medical Group Holdings Incorporated (SBCWW) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 43.06M | 39.57M | 43.35M | 43.36M | 47.33M | 44.42M | 53.09M | 53.1M | 54.81M | 62.35M | 47.28M | 0 |
| Revenue Growth % | -9.02% | -10.93% | -18.33% | -18.35% | -13.65% | -28.76% | 12.28% | - | - | - | - | - |
| Cost of Goods Sold | 13.02M | 10.64M | 12.74M | 13.35M | 9.6M | 10.55M | 9.85M | 13.68M | 15.29M | 18.98M | 13.78M | 0 |
| COGS % of Revenue | 30.25% | 26.89% | 29.39% | 30.79% | 20.27% | 23.75% | 18.55% | 25.77% | 27.89% | 30.44% | 29.15% | - |
| Gross Profit | 30.04M | 28.93M | 30.61M | 30.01M | 37.73M | 33.87M | 43.24M | 39.42M | 39.52M | 43.37M | 33.5M | 0 |
| Gross Margin % | 69.75% | 73.11% | 70.61% | 69.21% | 79.73% | 76.25% | 81.45% | 74.23% | 72.11% | 69.56% | 70.85% | - |
| Gross Profit Growth % | -20.4% | -14.59% | -29.2% | -23.87% | -4.52% | -21.9% | 29.08% | - | - | - | - | - |
| Operating Expenses | 12.32M | 16.08M | 14.73M | 15.46M | 13.53M | 29.16M | 29.4M | 12.13M | 15.06M | 19.38M | 13.48M | 473.37K |
| OpEx % of Revenue | 28.6% | 40.64% | 33.98% | 35.65% | 28.59% | 65.63% | 55.39% | 22.84% | 27.47% | 31.08% | 28.5% | - |
| Selling, General & Admin | 12.32M | 18.63M | 13.95M | 14.39M | 12.82M | 14.1M | 29.4M | 11.72M | 13.99M | 19.35M | 13.45M | 430.84K |
| SG&A % of Revenue | 28.6% | 47.09% | 32.18% | 33.19% | 27.1% | 31.73% | 55.39% | 22.07% | 25.52% | 31.03% | 28.44% | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | -1000K | 781.19K | 1000K | 706.87K | 1000K | 0 | 407.93K | 1000K | 28.26K | 28.52K | 42.53K |
| Operating Income | 17.72M | 12.85M | 15.88M | 14.55M | 24.2M | 4.72M | 13.84M | 27.29M | 24.46M | 23.99M | 20.02M | -473K |
| Operating Margin % | 41.15% | 32.47% | 36.63% | 33.57% | 51.14% | 10.62% | 26.06% | 51.39% | 44.63% | 38.48% | 42.35% | - |
| Operating Income Growth % | -26.78% | 172.34% | 14.79% | -46.67% | -1.06% | -80.33% | -30.91% | 5869.67% | - | - | 6694.88% | - |
| EBITDA | 18.39M | 13.52M | 16.63M | 15.19M | 24.83M | 5.65M | 14.85M | 28.12M | 25.48M | 26.55M | 21.07M | 363.51K |
| EBITDA Margin % | 42.71% | 34.18% | 38.35% | 35.03% | 52.46% | 12.72% | 27.98% | 52.96% | 46.49% | 42.58% | 44.57% | - |
| EBITDA Growth % | -25.94% | 139.35% | 11.95% | -45.98% | -2.55% | -78.72% | -29.52% | 7636.02% | - | - | 44518.12% | - |
| D&A (Non-Cash Add-back) | 670.43K | 673.68K | 746.21K | 636.1K | 628.3K | 931.6K | 1.02M | 830.95K | 1.02M | 2.56M | 0 | 0 |
| EBIT | 17.72M | 18.62M | 18.56M | 13.59M | 31.46M | 6.07M | 13.11M | 27.09M | 27.21M | 23.57M | 21.07M | 363.51K |
| Net Interest Income | 6.56K | -56.09K | 71.75K | -26.77K | 49.13K | -12.4K | 2.48K | 4.22K | 14.68K | -7.51K | 6.26K | 836.89K |
| Interest Income | 121.37K | 0 | 120.38K | 22.88K | 55.33K | 0 | 7.95K | 11.64K | 17.69K | 403 | 10.23K | 836.89K |
| Interest Expense | 114.81K | 56.09K | 48.63K | 49.65K | 6.21K | 12.4K | 5.47K | 7.42K | 3.01K | 7.91K | 3.98K | 0 |
| Other Income/Expense | 1.14M | 5.72M | 2.63M | -1.01M | 7.25M | 1.34M | -727K | -204.13K | 2.74M | -424.18K | 1.05M | 836.89K |
| Pretax Income | 18.86M | 18.57M | 18.51M | 13.54M | 31.45M | 6.06M | 13.11M | 27.09M | 27.2M | 23.57M | 21.07M | 363.51K |
| Pretax Margin % | 43.79% | 46.93% | 42.69% | 31.23% | 66.45% | 13.64% | 24.69% | 51.01% | 49.63% | 37.8% | 44.57% | - |
| Income Tax | 7.53M | 4.29M | 5.67M | 11.1M | 9.96M | -489K | 10.27M | 8.53M | 8.45M | 9.34M | 13.01M | 166.73K |
| Effective Tax Rate % | 39.92% | 23.09% | 30.66% | 81.98% | 31.67% | -8.07% | 78.37% | 31.49% | 31.07% | 39.62% | 61.76% | 45.87% |
| Net Income | 11.31M | 14.2M | 12.82M | 2.46M | 21.5M | 6.54M | 2.83M | 18.48M | 18.76M | 14.34M | 8.36M | 196.79K |
| Net Margin % | 26.26% | 35.89% | 29.58% | 5.67% | 45.43% | 14.72% | 5.34% | 34.81% | 34.22% | 23% | 17.67% | - |
| Net Income Growth % | -47.41% | 117.16% | 352.69% | -86.7% | 14.63% | -54.41% | -66.1% | 9293.15% | - | - | 73279.91% | - |
| Net Income (Continuing) | 11.33M | 14.28M | 12.83M | 2.44M | 21.49M | 6.55M | 2.83M | 18.56M | 18.75M | 14.23M | 8.06M | 196.79K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 15.04M | 15.02M | 70.91K | 60.58K | -123.83K | -87K | 539.37K | 0 | 0 | 1.65M | 0 | 0 |
| EPS (Diluted) | 0.11 | 0.14 | 0.12 | 0.02 | 0.21 | 0.06 | 0.03 | 0.20 | -0.05 | -0.04 | -0.02 | 0.02 |
| EPS Growth % | -47.62% | 120.13% | 302.68% | -88.1% | 482.51% | 245.54% | 256.84% | 866.18% | - | - | - | - |
| EPS (Basic) | 0.11 | 0.14 | 0.12 | 0.02 | 0.21 | 0.06 | 0.03 | 0.44 | -0.05 | -0.04 | -0.02 | 0.02 |
| Diluted Shares Outstanding | 102.58M | 102.58M | 102.64M | 103.51M | 103.28M | 102.75M | 95.09M | 5.22M | 5.32M | 8.37M | 5.49M | 9.49M |
| Basic Shares Outstanding | 102.58M | 102.58M | 102.64M | 103.51M | 103.28M | 102.75M | 95.09M | 5.22M | 5.32M | 8.37M | 5.49M | 9.49M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | 1197.63% | 50856.71% |